118 related articles for article (PubMed ID: 16715493)
1. High resolution spatial mapping of nicotine action using pharmacologic magnetic resonance imaging.
Choi JK; Mandeville JB; Chen YI; Kim YR; Jenkins BG
Synapse; 2006 Aug; 60(2):152-7. PubMed ID: 16715493
[TBL] [Abstract][Full Text] [Related]
2. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
Skoubis PD; Hradil V; Chin CL; Luo Y; Fox GB; McGaraughty S
Neuroscience; 2006; 137(2):583-91. PubMed ID: 16289887
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
4. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI.
Chen YI; Choi JK; Jenkins BG
Synapse; 2005 Feb; 55(2):80-8. PubMed ID: 15529335
[TBL] [Abstract][Full Text] [Related]
5. A comparison of brain and behavioral effects of varenicline and nicotine in rats.
King J; Huang W; Chen W; Heffernan M; Shields J; Rane P; Bircher R; DiFranza JR
Behav Brain Res; 2011 Sep; 223(1):42-7. PubMed ID: 21527291
[TBL] [Abstract][Full Text] [Related]
6. Sub-chronic nicotine-induced changes in regional cerebral blood volume and transversal relaxation time patterns in the rat: a magnetic resonance study.
Calderan L; Chiamulera C; Marzola P; Fabene PF; Fumagalli GF; Sbarbati A
Neurosci Lett; 2005 Apr; 377(3):195-9. PubMed ID: 15755525
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological MRI in awake rats predicts selective binding of alpha4beta2 nicotinic receptors.
Chin CL; Pauly JR; Surber BW; Skoubis PD; McGaraughty S; Hradil VP; Luo Y; Cox BF; Fox GB
Synapse; 2008 Mar; 62(3):159-68. PubMed ID: 18081183
[TBL] [Abstract][Full Text] [Related]
8. The effects of acetaldehyde on nicotine-induced transmitter levels in young and adult brain areas.
Sershen H; Shearman E; Fallon S; Chakraborty G; Smiley J; Lajtha A
Brain Res Bull; 2009 Aug; 79(6):458-62. PubMed ID: 19389462
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes.
Domino EF; Ni L; Xu Y; Koeppe RA; Guthrie S; Zubieta JK
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):319-27. PubMed ID: 14751429
[TBL] [Abstract][Full Text] [Related]
10. A study paradigm allowing comparison of multiple high-resolution rCBV-maps for the examination of drug effects.
Rausch M; Gentsch C; Enz A; Baumann D; Rudin M
NMR Biomed; 2005 Jun; 18(4):260-8. PubMed ID: 15759291
[TBL] [Abstract][Full Text] [Related]
11. Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain.
Schwarz A; Gozzi A; Reese T; Bertani S; Crestan V; Hagan J; Heidbreder C; Bifone A
Synapse; 2004 Oct; 54(1):1-10. PubMed ID: 15300879
[TBL] [Abstract][Full Text] [Related]
12. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers.
Domino EF; Minoshima S; Guthrie S; Ohl L; Ni L; Koeppe RA; Zubieta JK
Synapse; 2000 Dec; 38(3):313-21. PubMed ID: 11020234
[TBL] [Abstract][Full Text] [Related]
13. Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat.
Gozzi A; Schwarz AJ; Reese T; Crestan V; Bertani S; Turrini G; Corsi M; Bifone A
J Neurosci Methods; 2005 Mar; 142(1):115-24. PubMed ID: 15652624
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
15. Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naïve rat.
Gozzi A; Schwarz A; Reese T; Bertani S; Crestan V; Bifone A
Neuropsychopharmacology; 2006 Aug; 31(8):1690-703. PubMed ID: 16292320
[TBL] [Abstract][Full Text] [Related]
16. The neuronal pathways mediating the behavioral and addictive properties of nicotine.
Balfour DJ
Handb Exp Pharmacol; 2009; (192):209-33. PubMed ID: 19184651
[TBL] [Abstract][Full Text] [Related]
17. Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessment.
Luo F; Schmidt KF; Fox GB; Ferris CF
J Psychiatr Res; 2009 Aug; 43(12):1018-24. PubMed ID: 19135215
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging studies of cigarette smoking.
Azizian A; Monterosso J; O'Neill J; London ED
Handb Exp Pharmacol; 2009; (192):113-43. PubMed ID: 19184648
[TBL] [Abstract][Full Text] [Related]
19. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression.
Zhu J; Bardo MT; Bruntz RC; Stairs DJ; Dwoskin LP
Eur J Neurosci; 2007 Aug; 26(3):717-28. PubMed ID: 17651428
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control.
Thiel CM; Fink GR
Neuroscience; 2008 Mar; 152(2):381-90. PubMed ID: 18272290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
